Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

AIMS: To compare the efficacy and safety of adding the glucagon‐like peptide‐1 receptor agonist exenatide once weekly (QW) 2 mg or placebo among patients with type 2 diabetes who were inadequately controlled despite titrated insulin glargine (IG) ± metformin. METHODS: This multicentre, double‐blind...

Descripción completa

Detalles Bibliográficos
Autores principales: Guja, Cristian, Frías, Juan P., Somogyi, Aniko, Jabbour, Serge, Wang, Hui, Hardy, Elise, Rosenstock, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032936/
https://www.ncbi.nlm.nih.gov/pubmed/29473704
http://dx.doi.org/10.1111/dom.13266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032936/
https://www.ncbi.nlm.nih.gov/pubmed/29473704
http://dx.doi.org/10.1111/dom.13266

Ejemplares similares